<DOC>
	<DOCNO>NCT00208039</DOCNO>
	<brief_summary>A research study evaluate give surfactant medication premature baby weigh &lt; 1250 gm birth second third week life help lung . We enrol premature baby continue require breathing tube mechanical ventilator day 7-10 life .</brief_summary>
	<brief_title>Pilot Trial Surfactant Booster Prophylaxis For Ventilated Preterm Neonates</brief_title>
	<detailed_description>Pulmonary surfactant require normal lung function . Data previous study suggest many 75 % chronically ventilate extremely low birthweight premature infant least one episode surfactant dysfunction beyond first week life , measure vitro , associate low surfactant protein B content . Furthermore , episode surfactant dysfunction significantly associate clinically significant respiratory decompensations . We hypothesize booster dos surfactant give second third week life extremely low birth weight premature infant require persistent intubation mechanical ventilation improve respiratory status first 28 day life . We propose enroll premature infant &lt; 1250 gm birthweight , day 7 10 life intubate , mechanically ventilate . Infants require persistent intubation mechanical ventilation respiratory support 7-10 day life receive total 3 dos Infasurf surfactant , 3 day apart , standard dose 3 ml/kg . Primary outcome change area respiratory severity score curve day 7 28 life . Total sample size 88 infant , study duration 36 month , recruitment study patient occur The Hospital University Pennsylvania , Philadelphia PA , Women Children 's Hospital Buffalo , St. Louis Children 's Hospital St. Louis MO , Mercy Children 's Hospital Kansas City , Oakland Children 's Alta Bates Medical Center Berkeley , CA Long Island Jewish Medical Center , NY .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Calfactant</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Less equal to1250 gm birthweight Day 710 life Intubated mechanically ventilate day 710 life Infants intubate solely apnea Serious congenital malformation Life expectancy &lt; 7 day enrollment Pulmonary hemorrhage time enrollment Active air leak syndrome time enrollment Bilateral grade IV intracranial hemorrhage Postnatal systemic steroid therapy lung disease Note : Prior surfactant therapy birth neither inclusion exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Days</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Prematurity</keyword>
	<keyword>Lung Disease</keyword>
	<keyword>Hyaline Membrane</keyword>
	<keyword>Surfactant</keyword>
</DOC>